Publications by authors named "Joseph Alex Davis"

Claim this Profile
A
Antihyperglycemic effect of Annona squamosa hexane extract in type 2 diabetes animal model: PTP1B inhibition, a possible mechanism of action?
Joseph Alex Davis, Suchitra Sharma, Shivani Mittra, S Sujatha, Anil Kanaujia

Indian J Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Shuchita Singh, Subhasis Roy, Sachin Sethi, Biju Benjamin, Sindhuja Sundaram, Joseph Alex Davis

Eur J Pharmacol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes.
Sameer Sharma, Chandra Sekhar Misra, Surendar Arumugam, Subhasis Roy, Vanya Shah, Joseph Alex Davis

Phytother Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baculovirus expression system: an alternative for producing catalytically active human PTP-1B.
Sindhuja Sundaram, Prabhakar Tiwari, Shalini Saini, Rajiv Kant, Joseph Alex Davis

Mol Biol (Mosk)· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of berberine as a novel agonist of fatty acid receptor GPR40.
Geetha Vani Rayasam, Vamshi Krishna Tulasi, Sindhuja Sundaram, Winny Singh, Rajiv Kant, Joseph Alex Davis

Phytother Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative deacetylase activity of wild type and mutants of SIRT1.
Renu Malik, Akriti Kashyap, Karuna Bansal, Pratibha Sharma, Geeta Vani Rayasam, Joseph Alex Davis

Biochem Biophys Res Commun· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycogen synthase kinase 3: more than a namesake.
Geetha Vani Rayasam, Vamshi Krishna Tulasi, Reena Sodhi, Joseph Alex Davis, Abhijit Ray

Br J Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid receptors as new therapeutic targets for diabetes.
Geetha Vani Rayasam, Vamshi Krishna Tulasi, Joseph Alex Davis, Vinay S Bansal

Expert Opin Ther Targets· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation.
Claudia Mandato, Lena Brive, Yoshiaki Miura, Joseph Alex Davis, Nicolina Di Cosmo

Pediatr Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis